No more candidate donations from Glaxo

GlaxoSmithKline announced that it won't spend corporate money on political contributions anymore, saying that it wants to avoid the implication "that corporate political contributions provide us with any special privileges." The company donated more than $585,000 to U.S. candidates this election year. Release | Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.